RECURRENT LIPOSARCOMA

Clinical trials for RECURRENT LIPOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT LIPOSARCOMA trials appear

Sign up with your email to follow new studies for RECURRENT LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough cancers: experimental drug targets rare sarcomas

Disease control Recruiting now

This early-stage study is testing whether a new drug called BTX-A51 is safe for people with advanced liposarcoma, a rare type of cancer. Researchers will give the drug to about 24 patients whose cancer has returned or spread, and monitor them closely for side effects. The study w…

Matched conditions: RECURRENT LIPOSARCOMA

Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

RECURRENT LIPOSARCOMA

Get alerted when new RECURRENT LIPOSARCOMA trials appear

New hope for tough cancers: experimental drug targets rare sarcomas